Regencell Bioscience Holdings Ltd

Regencell Bioscience Holdings Ltd (RGC) has reported zero cyber incidents and zero red-flag 8-K filings over the past 90 days, suggesting relative operational stability in our near-term window. However, low signal in a 90-day snapshot does not indicate overall risk status; biotech companies face structural risks that emerge across longer timelines. The full $49 Report extends analysis to 12 months of SEC filings, adds a dilution risk score, maps financing history, and surfaces AI-detected risk signals tied to clinical, regulatory, and capital structure developments. The full $49 Report adds institutional-grade context on shareholder dilution trajectory, 8-K event causality, and forward-looking risk factors beyond our current detection window.